Results 41 to 50 of about 54,639 (294)

Coexisting Cardiac and Hematologic Disorders. [PDF]

open access: yes, 2016
Patients with concomitant cardiac and hematologic disorders presenting for noncardiac surgery are challenging. Anemic patients with cardiac disease should be approached in a methodical fashion.
Goldhammer, Jordan E., Kohl, Benjamin A.
core   +3 more sources

Eltrombopag for the treatment of immune thrombocytopenia: The aegean region of Turkey experience [PDF]

open access: yes, 2015
Objective: Immune thrombocytopenia (ITP) is an immune-mediated disease characterized by transient or persistent decrease of the platelet count to less than 100x109/L. Although it is included in a benign disease group, bleeding complications may be mortal.
Alacacıoğlu, İ.   +21 more
core   +3 more sources

Plasma levels of S100A8/A9, histone/DNA complexes, and cell‐free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura

open access: yesJournal of Thrombosis and Haemostasis, 2020
Immune thrombotic thrombocytopenic purpura (iTTP) is a life‐threatening blood disorder, primarily resulting from autoantibodies against ADAMTS13. Infection or inflammation often precedes acute iTTP.
Jingrui Sui   +6 more
semanticscholar   +1 more source

Secondary immune thrombocytopenic purpura with renal cell carcinoma

open access: yesIJU Case Reports, 2019
Introduction Several types of cancers are reported to induce secondary immune thrombocytopenia resembling immune thrombocytopenic purpura‐like syndrome. However, renal cell carcinoma‐induced immune thrombocytopenic purpura is an extremely rare phenomenon.
Shigeaki Nakazawa   +9 more
doaj   +1 more source

How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome [PDF]

open access: yes, 2014
Thrombotic thrombocytopenic purpura (TTP) and atypical haemolytic uraemic syndrome (aHUS) are acute, rare life-threatening thrombotic microangiopathies that require rapid diagnosis and treatment.
Goodship, T, Scully, M
core   +1 more source

Immunogenic hotspots in the spacer domain of ADAMTS13 in immune‐mediated thrombotic thrombocytopenic purpura

open access: yesJournal of Thrombosis and Haemostasis, 2020
Immune‐mediated thrombotic thrombocytopenic purpura (iTTP) is caused by anti‐ADAMTS13 autoantibodies inducing a severe deficiency of ADAMTS13. Epitope mapping studies on samples obtained during acute iTTP episodes have shown that the iTTP immune response
Leydi Carolina Velásquez Pereira   +20 more
semanticscholar   +1 more source

Immune Thrombocytopenia as a Consequence of Rocky Mountain Spotted Fever

open access: yesCase Reports in Oncology, 2017
Primary immune thrombocytopenia (ITP) – also called idiopathic thrombocytopenic purpura or immune thrombocytopenic purpura – is an acquired thrombocytopenia caused by autoantibodies against platelet antigens.
Cherisse Baldeo   +2 more
doaj   +1 more source

Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023

open access: yesInternational journal of hematology, 2023
Thrombotic thrombocytopenic purpura (TTP) can rapidly become a life-threatening condition, and the importance of its appropriate diagnosis and treatment cannot be overstated.
M. Matsumoto   +11 more
semanticscholar   +1 more source

Discussion required for correct interpretation [PDF]

open access: yes, 2006
Thank you for the opportunity to comment on the editorial by Romero and colleagues [1], which raises a number of important and interesting questions.
Aguan   +10 more
core   +3 more sources

Evaluation of the diagnostic performance of platelet-derived indices for the differential diagnosis of thrombocytopenia in pediatrics

open access: yesRevista de la Facultad de Medicina, 2014
Background. Platelet-derived indices have a well-established correlation with the differential diagnosis of thrombocytopenia in adult-based research. These indices include mean platelet volume, platelet distribution width, and platelet-large cell ratio.
Nelson Hernando Aponte Barrios   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy